Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Por Yao Xiong, Yin Guo, Ye Liu, Hexiang Wang, Wenfeng Gong, Yong Liu, Xing Wang, Yajuan Gao, Fenglong Yu, Dan Su, Fan Wang, Yutong Zhu, Yuan Zhao, Yiyuan Wu, Zhen Qin, Xuebing Sun, Bo Ren, Bin Jiang, Wei Jin, Zhirong Shen, Zhiyu Tang, Xiaomin Song, Lai Wang, Xuesong Liu, Changyou Zhou, Beibei Jiang
Publicado em 2020-09-01

NURS-02. CAR-T CELL THERAPY IN PEDIATRIC BRAIN TUMORS- EARLY SUPPORTIVE CARE LESSONS

Por Hoeppner, Corrine, Holtzclaw, Susan
Publicado no Neuro Oncol (2018)

Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases

Por McPherson, Christopher M., Suki, Dima, Feiz-Erfan, Iman, Mahajan, Anita, Chang, Eric, Sawaya, Raymond, Lang, Frederick F.
Publicado em 2010

Glioblastoma’s Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research

Por Caragher, Seamus, Chalmers, Anthony J., Gomez-Roman, Natividad
Publicado no Cancers (Basel) (2019)

Hippocampal Dosimetry Predicts Neurocognitive Function Impairment After Fractionated Stereotactic Radiotherapy for Benign or Low-Grade Adult Brain Tumors

Por Gondi, Vinai, Hermann, Bruce P., Mehta, Minesh P., Tomé, Wolfgang A.
Publicado em 2011

TMIC-12. REPROGRAMMING THE BRAIN TUMOR MICROENVIRONMENT WITH HEMATOPOIETIC STEM AND PROGENITOR CELLS

Por Wildes, Tyler, Flores, Catherine, Mitchell, Duane
Publicado no Neuro Oncol (2017)

Current Vaccine Trials in Glioblastoma: A Review

Por Xu, Linda W., Chow, Kevin K. H., Lim, Michael, Li, Gordon
Publicado em 2014

IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY

Por Ampudia-Mesias, Elisabet, Moertel, Christopher, Olin, Michael
Publicado no Neuro Oncol (2017)

Updates on Molecular Targeted Therapies for CNS Tumors

Publicado em 2023

CADD-30. A TREATMENT SIMULATOR FOR BRAIN CHEMOTHERAPY

Por Broaddus, William, Raghavan, Raghu
Publicado no Neuro Oncol (2018)

Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

Por Yamashita, Yoji, Krauze, Michal T., Kawaguchi, Tomohiro, Noble, Charles O., Drummond, Daryl C., Park, John W., Bankiewicz, Krystof S.
Publicado em 2007

Role of bevacizumab therapy in the management of glioblastoma

Por Peak, Scott J, Levin, Victor A
Publicado em 2010

Analysis of 2000 cases treated with gamma knife surgery: validating eligibility criteria for a prospective multi-institutional study of stereotactic radiosurgery alone for treatment of patients with 1-10...

Por Serizawa, Toru, Higuchi, Yoshinori, Nagano, Osamu, Sato, Yasunori, Yamamoto, Masaaki, Ono, Junichi, Saeki, Naokatsu, Miyakawa, Akifumi, Hirai, Tatsuo
Publicado no J Radiosurg SBRT (2012)

SIG-03. HHIP-AS1 PROMOTES TUMOR SURVIVAL THROUGH STABILIZING DYNEIN COMPLEX 1 IN HEDGEHOG DRIVEN HUMAN BRAIN TUMORS

Por Bartl, Jasmin, Forget, Antoine, Zanini, Marco, Picard, Daniel, Qin, Nan, Borkhardt, Arndt, Reifenberger, Guido, Ayrault, Olivier, Remke, Marc
Publicado no Neuro Oncol (2019)

Randomized Controlled Trial of Prophylactic Phenytoin After Neurosurgery for Brain Tumor

Por Penovich, Patricia E.
Publicado em 2002

CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN...

Por Roberge, David, Brown, Paul, Mason, Warren, O’Callaghan, Chris, Ding, Keyue, Whitton, Anthony, Chan, Michael D
Publicado no Neuro Oncol (2017)

P07.01 The CAR2BRAIN study: a monocentric phase I trial with ErbB2-specific NK-92/5.28.z cells in recurrent glioblastoma

Por Burger, M. C., Mildenberger, I. C., Cieplik, H. C., Zhang, C., Jennewein, L., Ihrig, K., Wagner, M., Mittelbronn, M., Senft, C., Tonn, T., Wels, W. S., Steinbach, J. P.
Publicado no Neuro Oncol (2017)

Immunotherapy for Medulloblastoma: Current Perspectives

Por Kabir TF, Kunos CA, Villano JL, Chauhan A
Publicado em 2020-04-01

Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease

Por Loza, Matthew J, Watt, Rosemary, Baribaud, Frédéric, Barnathan, Elliot S, Rennard, Stephen I
Publicado em 2012

P09.57 Clinical trials of VAL-083 in patients with chemoresistant glioblastoma

Por Bacha, J. A., Steino, A., Schwartz, R., Langlands, J., Kanekal, S., Lopez, L. M., Brown, D. M.
Publicado no Neuro Oncol (2017)